<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d487" origId="Bivalirudin"><sentence id="DrugDDI.d487.s0" origId="s0" text="Angiomax does not exhibit binding to plasma proteins (other than thrombin) or red blood cells."><entity id="DrugDDI.d487.s0.e0" origId="s0.p0" charOffset="0-8" type="drug" text="Angiomax"/><entity id="DrugDDI.d487.s0.e1" origId="s0.p5" charOffset="37-52" type="drug" text="plasma proteins"/><entity id="DrugDDI.d487.s0.e2" origId="s0.p7" charOffset="65-73" type="drug" text="thrombin"/><entity id="DrugDDI.d487.s0.e3" origId="s0.p10" charOffset="78-93" type="drug" text="red blood cells"/><pair id="DrugDDI.d487.s0.p0" e1="DrugDDI.d487.s0.e0" e2="DrugDDI.d487.s0.e1" interaction="false"/><pair id="DrugDDI.d487.s0.p1" e1="DrugDDI.d487.s0.e0" e2="DrugDDI.d487.s0.e2" interaction="false"/><pair id="DrugDDI.d487.s0.p2" e1="DrugDDI.d487.s0.e0" e2="DrugDDI.d487.s0.e3" interaction="false"/><pair id="DrugDDI.d487.s0.p3" e1="DrugDDI.d487.s0.e1" e2="DrugDDI.d487.s0.e2" interaction="false"/><pair id="DrugDDI.d487.s0.p4" e1="DrugDDI.d487.s0.e1" e2="DrugDDI.d487.s0.e3" interaction="false"/><pair id="DrugDDI.d487.s0.p5" e1="DrugDDI.d487.s0.e2" e2="DrugDDI.d487.s0.e3" interaction="false"/></sentence><sentence id="DrugDDI.d487.s1" origId="s1" text="In clinical trials in patients undergoing PTCA/PCI, co-administration of Angiomax with heparin, warfarin, thrombolytics or glycoprotein IIb/IIIa inhibitors was associated with increased risks of major bleeding events compared to patients not receiving these concomitant medications."><entity id="DrugDDI.d487.s1.e0" origId="s1.p13" charOffset="47-50" type="drug" text="PCI"/><entity id="DrugDDI.d487.s1.e1" origId="s1.p15" charOffset="73-81" type="drug" text="Angiomax"/><entity id="DrugDDI.d487.s1.e2" origId="s1.p16" charOffset="87-94" type="drug" text="heparin"/><entity id="DrugDDI.d487.s1.e3" origId="s1.p17" charOffset="96-104" type="drug" text="warfarin"/><entity id="DrugDDI.d487.s1.e4" origId="s1.p18" charOffset="106-118" type="drug" text="thrombolytic"/><entity id="DrugDDI.d487.s1.e5" origId="s1.p20" charOffset="123-135" type="drug" text="glycoprotein"/><entity id="DrugDDI.d487.s1.e6" origId="s1.p30" charOffset="270-281" type="drug" text="medications"/><pair id="DrugDDI.d487.s1.p0" e1="DrugDDI.d487.s1.e0" e2="DrugDDI.d487.s1.e1" interaction="false"/><pair id="DrugDDI.d487.s1.p1" e1="DrugDDI.d487.s1.e0" e2="DrugDDI.d487.s1.e2" interaction="false"/><pair id="DrugDDI.d487.s1.p2" e1="DrugDDI.d487.s1.e0" e2="DrugDDI.d487.s1.e3" interaction="false"/><pair id="DrugDDI.d487.s1.p3" e1="DrugDDI.d487.s1.e0" e2="DrugDDI.d487.s1.e4" interaction="false"/><pair id="DrugDDI.d487.s1.p4" e1="DrugDDI.d487.s1.e0" e2="DrugDDI.d487.s1.e5" interaction="false"/><pair id="DrugDDI.d487.s1.p5" e1="DrugDDI.d487.s1.e0" e2="DrugDDI.d487.s1.e6" interaction="false"/><pair id="DrugDDI.d487.s1.p6" e1="DrugDDI.d487.s1.e1" e2="DrugDDI.d487.s1.e2" interaction="true"/><pair id="DrugDDI.d487.s1.p7" e1="DrugDDI.d487.s1.e1" e2="DrugDDI.d487.s1.e3" interaction="true"/><pair id="DrugDDI.d487.s1.p8" e1="DrugDDI.d487.s1.e1" e2="DrugDDI.d487.s1.e4" interaction="true"/><pair id="DrugDDI.d487.s1.p9" e1="DrugDDI.d487.s1.e1" e2="DrugDDI.d487.s1.e5" interaction="true"/><pair id="DrugDDI.d487.s1.p10" e1="DrugDDI.d487.s1.e1" e2="DrugDDI.d487.s1.e6" interaction="false"/><pair id="DrugDDI.d487.s1.p11" e1="DrugDDI.d487.s1.e2" e2="DrugDDI.d487.s1.e3" interaction="false"/><pair id="DrugDDI.d487.s1.p12" e1="DrugDDI.d487.s1.e2" e2="DrugDDI.d487.s1.e4" interaction="false"/><pair id="DrugDDI.d487.s1.p13" e1="DrugDDI.d487.s1.e2" e2="DrugDDI.d487.s1.e5" interaction="false"/><pair id="DrugDDI.d487.s1.p14" e1="DrugDDI.d487.s1.e2" e2="DrugDDI.d487.s1.e6" interaction="false"/><pair id="DrugDDI.d487.s1.p15" e1="DrugDDI.d487.s1.e3" e2="DrugDDI.d487.s1.e4" interaction="false"/><pair id="DrugDDI.d487.s1.p16" e1="DrugDDI.d487.s1.e3" e2="DrugDDI.d487.s1.e5" interaction="false"/><pair id="DrugDDI.d487.s1.p17" e1="DrugDDI.d487.s1.e3" e2="DrugDDI.d487.s1.e6" interaction="false"/><pair id="DrugDDI.d487.s1.p18" e1="DrugDDI.d487.s1.e4" e2="DrugDDI.d487.s1.e5" interaction="false"/><pair id="DrugDDI.d487.s1.p19" e1="DrugDDI.d487.s1.e4" e2="DrugDDI.d487.s1.e6" interaction="false"/><pair id="DrugDDI.d487.s1.p20" e1="DrugDDI.d487.s1.e5" e2="DrugDDI.d487.s1.e6" interaction="false"/></sentence><sentence id="DrugDDI.d487.s2" origId="s2" text="There is no experience with co-administration of Angiomax and plasma expanders such as dextran."><entity id="DrugDDI.d487.s2.e0" origId="s2.p35" charOffset="49-57" type="drug" text="Angiomax"/><entity id="DrugDDI.d487.s2.e1" origId="s2.p37" charOffset="62-77" type="drug" text="plasma expander"/><entity id="DrugDDI.d487.s2.e2" origId="s2.p38" charOffset="87-94" type="drug" text="dextran"/><pair id="DrugDDI.d487.s2.p0" e1="DrugDDI.d487.s2.e0" e2="DrugDDI.d487.s2.e1" interaction="false"/><pair id="DrugDDI.d487.s2.p1" e1="DrugDDI.d487.s2.e0" e2="DrugDDI.d487.s2.e2" interaction="false"/><pair id="DrugDDI.d487.s2.p2" e1="DrugDDI.d487.s2.e1" e2="DrugDDI.d487.s2.e2" interaction="false"/></sentence><sentence id="DrugDDI.d487.s3" origId="s3" text="Angiomax should be used with caution in patients with disease states associated with an increased risk of bleeding."><entity id="DrugDDI.d487.s3.e0" origId="s3.p39" charOffset="0-8" type="drug" text="Angiomax"/></sentence><sentence id="DrugDDI.d487.s4" origId="s4" text="Immunogenicity/Re-exposure: In in vitro studies, Angiomax exhibited no platelet aggregation response against sera from patients with a history of HIT/HITTS."><entity id="DrugDDI.d487.s4.e0" origId="s4.p53" charOffset="49-57" type="drug" text="Angiomax"/></sentence><sentence id="DrugDDI.d487.s5" origId="s5" text="Among 494 subjects who received Angiomax in clinical trials and were tested for antibodies, 2 subjects had treatment-emergent positive bivalirudin antibody tests."><entity id="DrugDDI.d487.s5.e0" origId="s5.p64" charOffset="32-40" type="drug" text="Angiomax"/><entity id="DrugDDI.d487.s5.e1" origId="s5.p69" charOffset="80-90" type="drug" text="antibodies"/><entity id="DrugDDI.d487.s5.e2" origId="s5.p72" charOffset="135-146" type="drug" text="bivalirudin"/><pair id="DrugDDI.d487.s5.p0" e1="DrugDDI.d487.s5.e0" e2="DrugDDI.d487.s5.e1" interaction="false"/><pair id="DrugDDI.d487.s5.p1" e1="DrugDDI.d487.s5.e0" e2="DrugDDI.d487.s5.e2" interaction="false"/><pair id="DrugDDI.d487.s5.p2" e1="DrugDDI.d487.s5.e1" e2="DrugDDI.d487.s5.e2" interaction="false"/></sentence><sentence id="DrugDDI.d487.s6" origId="s6" text="Neither subject demonstrated clinical evidence of allergic or anaphylactic reactions and repeat testing was not performed."/><sentence id="DrugDDI.d487.s7" origId="s7" text="Nine additional patients who had initial positive tests were negative on repeat testing."/></document>